International News

Mylan Subsidiary Starts Operations in India

From CDC National Prevention Information Network

August 9, 2012

Pennsylvania-based Mylan Inc. said a subsidiary has launched commercial operations in India, beginning with HIV/AIDS drugs. After initially offering 18 antiretrovirals, Mylan Pharmaceuticals Private Ltd. plans to add therapeutic categories and enlarge its sales force. Mylan already is active in the nation, having acquired a majority stake in Matrix Laboratories of India in 2007 and bought the remainder of the company in 2009. India is home to the world's third-largest population of HIV/AIDS patients, according to the National AIDS Control Organization.

Back to other news for August 2012

Adapted from:
Associated Press
08.06.2012

India's Contribution to Global Health R&D Needs Domestic, International Support

Attempts to Limit Intellectual Property Rights in India Could Harm Access to Generic Drugs

This article was provided by CDC National Prevention Information Network. It is a part of the publication CDC HIV/Hepatitis/STD/TB Prevention News Update.

More on HIV/AIDS Treatment in India

"You don't have to fight this fight by yourself." Watch Susan's Story >

More >>

TheBody.com App

Get Our Newsletters

My Health Tracker

Medication and Health Reminders

Assess Your Risk for HIV

The Body is a service of Remedy Health Media, LLC, 750 3rd Avenue, 6th Floor, New York, NY 10017. The Body and its logos are trademarks of Remedy Health Media, LLC, and its subsidiaries, which owns the copyright of The Body's homepage, topic pages, page designs and HTML code. General Disclaimer: The Body is designed for educational purposes only and is not engaged in rendering medical advice or professional services. The information provided through The Body should not be used for diagnosing or treating a health problem or a disease. It is not a substitute for professional care. If you have or suspect you may have a health problem, consult your health care provider.